This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Löser, P.
Right arrow Articles by Sandig, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Löser, P.
Right arrow Articles by Sandig, V.

 Previous Article  |  Next Article 

J. Virol., 01 1998, 180-190, Vol 72, No. 1
Copyright © 1998, American Society for Microbiology

Reactivation of the previously silenced cytomegalovirus major immediate- early promoter in the mouse liver: involvement of NFkappaB

P Loser, GS Jennings, M Strauss and V Sandig
Department of Molecular Cell Biology, Humboldt-Universitat, Berlin, Germany.

The cytomegalovirus (CMV) major immediate-early promoter/enhancer is active in many cell culture systems and is considered to be one of the strongest promoters in vitro. However, when this promoter was used in in vivo approaches to gene therapy, it was silenced within a few weeks in several organs including the liver. In this study, we demonstrated transcriptional inactivation of the CMV promoter in mouse liver. In contrast to the CMV promoter, a hybrid promoter consisting of a minimal CMV promoter and the enhancer II of hepatitis B virus was active for at least 11 weeks in mouse liver. While investigating the reason for the shutdown of the CMV promoter, we did not find evidence for methylation of adenovirus DNA in the region of transgene insertion, but we could show that the silenced CMV promoter was reactivated after lipopolysaccharide treatment of mice or partial hepatectomy. Both stimuli are known to activate the transcription factor NFkappaB, which binds to four sites in the CMV promoter/enhancer. We show that expression from the CMV promoter in hepatocyte-derived cell lines in vitro depends on NFkappaB. In vivo experiments demonstrate that NFkappaB, which is not present in mouse hepatocytes in vivo, is activated after infection with recombinant adenoviruses and that the time course of NFkappaB activation parallels that of CMV promoter- dependent expression. Moreover, adenovirus infection of transgenic mice carrying a CMV promoter-driven lacZ gene leads to strong activation of the expression of this gene in the liver. Thus, NFkappaB is involved in the activation of the CMV promoter in the liver.


This article has been cited by other articles:

  • Harel-Markowitz, E., Gurevich, M., Shore, L. S., Katz, A., Stram, Y., Shemesh, M. (2009). Use of Sperm Plasmid DNA Lipofection Combined with REMI (Restriction Enzyme-Mediated Insertion) for Production of Transgenic Chickens Expressing eGFP (Enhanced Green Fluorescent Protein) or Human Follicle-Stimulating Hormone. Biol. Reprod. 80: 1046-1052 [Abstract] [Full Text]  
  • Gallaher, S. D., Gil, J. S., Dorigo, O., Berk, A. J. (2009). Robust In Vivo Transduction of a Genetically Stable Epstein-Barr Virus Episome to Hepatocytes in Mice by a Hybrid Viral Vector. J. Virol. 83: 3249-3257 [Abstract] [Full Text]  
  • Rodino-Klapac, L. R., Lee, J-S, Mulligan, R. C., Clark, K. R., Mendell, J. R. (2008). Lack of toxicity of alpha-sarcoglycan overexpression supports clinical gene transfer trial in LGMD2D. Neurology 71: 240-247 [Abstract] [Full Text]  
  • Park, C. Y., Chuck, R. S., Cano, M., Yew, M., Nguyen, V., Parker, J., Mori, K., Gehlbach, P. L. (2008). Periocular Triamcinolone Enhances Intraocular Gene Expression after Delivery by Adenovirus. IOVS 49: 399-406 [Abstract] [Full Text]  
  • Kim, K. I., Kang, J. H., Chung, J.-K., Lee, Y. J., Jeong, J. M., Lee, D. S., Lee, M. C. (2007). Doxorubicin Enhances the Expression of Transgene Under Control of the CMV Promoter in Anaplastic Thyroid Carcinoma Cells. JNM 48: 1553-1561 [Abstract] [Full Text]  
  • Simon, C. O., Kuhnapfel, B., Reddehase, M. J., Grzimek, N. K. A. (2007). Murine Cytomegalovirus Major Immediate-Early Enhancer Region Operating as a Genetic Switch in Bidirectional Gene Pair Transcription. J. Virol. 81: 7805-7810 [Abstract] [Full Text]  
  • Lee, T. K., Poon, R. T.P., Yuen, A. P., Ling, M. T., Kwok, W. K., Wang, X. H., Wong, Y. C., Guan, X. Y., Man, K., Chau, K. L., Fan, S. T. (2006). Twist Overexpression Correlates with Hepatocellular Carcinoma Metastasis through Induction of Epithelial-Mesenchymal Transition.. Clin. Cancer Res. 12: 5369-5376 [Abstract] [Full Text]  
  • Cook, C. H., Trgovcich, J., Zimmerman, P. D., Zhang, Y., Sedmak, D. D. (2006). Lipopolysaccharide, Tumor Necrosis Factor Alpha, or Interleukin-1{beta} Triggers Reactivation of Latent Cytomegalovirus in Immunocompetent Mice.. J. Virol. 80: 9151-9158 [Abstract] [Full Text]  
  • Strang, B. L., Takeuchi, Y., Relander, T., Richter, J., Bailey, R., Sanders, D. A., Collins, M. K. L., Ikeda, Y. (2005). Human Immunodeficiency Virus Type 1 Vectors with Alphavirus Envelope Glycoproteins Produced from Stable Packaging Cells. J. Virol. 79: 1765-1771 [Abstract] [Full Text]  
  • Escher, G., Hoang, A., Georges, S., Tchoua, U., El-Osta, A., Krozowski, Z., Sviridov, D. (2005). Demethylation using the epigenetic modifier, 5-azacytidine, increases the efficiency of transient transfection of macrophages. J. Lipid Res. 46: 356-365 [Abstract] [Full Text]  
  • Wen, S., Graf, S., Massey, P. G., Dichek, D. A. (2004). Improved Vascular Gene Transfer With a Helper-Dependent Adenoviral Vector. Circulation 110: 1484-1491 [Abstract] [Full Text]  
  • Rucker, M., Fraites, T. J. Jr, Porvasnik, S. L., Lewis, M. A., Zolotukhin, I., Cloutier, D. A., Byrne, B. J. (2004). Rescue of enzyme deficiency in embryonic diaphragm in a mouse model of metabolic myopathy: Pompe disease. Development 131: 3007-3019 [Abstract] [Full Text]  
  • Kobayashi, N., Matsui, Y., Kawase, A., Hirata, K., Miyagishi, M., Taira, K., Nishikawa, M., Takakura, Y. (2004). Vector-Based in Vivo RNA Interference: Dose- and Time-Dependent Suppression of Transgene Expression. J. Pharmacol. Exp. Ther. 308: 688-693 [Abstract] [Full Text]  
  • Grassi, G., Maccaroni, P., Meyer, R., Kaiser, H., D'Ambrosio, E., Pascale, E., Grassi, M., Kuhn, A., Di Nardo, P., Kandolf, R., Kupper, J.-H. (2003). Inhibitors of DNA methylation and histone deacetylation activate cytomegalovirus promoter-controlled reporter gene expression in human glioblastoma cell line U87. Carcinogenesis 24: 1625-1635 [Abstract] [Full Text]  
  • Ryffel, G. U., Werdien, D., Turan, G., Gerhards, A., Goosses, S., Senkel, S. (2003). Tagging muscle cell lineages in development and tail regeneration using Cre recombinase in transgenic Xenopus. Nucleic Acids Res 31: e44-e44 [Abstract] [Full Text]  
  • Vogler, C., Galvin, N., Levy, B., Grubb, J., Jiang, J., Zhou, X. Y., Sly, W. S. (2003). Transgene produces massive overexpression of human beta -glucuronidase in mice, lysosomal storage of enzyme, and strain-dependent tumors. Proc. Natl. Acad. Sci. USA 100: 2669-2673 [Abstract] [Full Text]  
  • Devin, C. J., Lee, Y.C. G., Light, R. W., Lane, K. B. (2003). Pleural Space as a Site of Ectopic Gene Delivery: Transfection of Pleural Mesothelial Cells With Systemic Distribution of Gene Product. Chest 123: 202-208 [Abstract] [Full Text]  
  • Tsai, M.-L., Chen, S.-L., Chou, P.-I, Wen, L.-Y., Tsai, R. J.-F., Tsao, Y.-P. (2002). Inducible Adeno-Associated Virus Vector-Delivered Transgene Expression in Corneal Endothelium. IOVS 43: 751-757 [Abstract] [Full Text]  
  • Harris, J. D., Graham, I. R., Schepelmann, S., Stannard, A. K., Roberts, M. L., Hodges, B. L., Hill, V., Amalfitano, A., Hassall, D. G., Owen, J. S., Dickson, G. (2002). Acute regression of advanced and retardation of early aortic atheroma in immunocompetent apolipoprotein-E (apoE) deficient mice by administration of a second generation [E1-, E3-, polymerase-] adenovirus vector expressing human apoE. Hum Mol Genet 11: 43-58 [Abstract] [Full Text]  
  • Zhang, H. J., Drake, V. J., Xu, L., Hu, J., Domann, F. E., Oberley, L. W., Kregel, K. C. (2002). Redox Regulation of Adenovirus-Induced AP-1 Activation by Overexpression of Manganese-Containing Superoxide Dismutase. J. Virol. 76: 355-363 [Abstract] [Full Text]  
  • Tallone, T., Malin, S., Samuelsson, A., Wilbertz, J., Miyahara, M., Okamoto, K., Poellinger, L., Philipson, L., Pettersson, S. (2001). A mouse model for adenovirus gene delivery. Proc. Natl. Acad. Sci. USA 98: 7910-7915 [Abstract] [Full Text]  
  • Grzimek, N. K. A., Dreis, D., Schmalz, S., Reddehase, M. J. (2001). Random, Asynchronous, and Asymmetric Transcriptional Activity of Enhancer-Flanking Major Immediate-Early Genes ie1/3 and ie2 during Murine Cytomegalovirus Latency in the Lungs. J. Virol. 75: 2692-2705 [Abstract] [Full Text]  
  • Bakri, Y., Schiffer, C., Zennou, V., Charneau, P., Kahn, E., Benjouad, A., Gluckman, J. C., Canque, B. (2001). The Maturation of Dendritic Cells Results in Postintegration Inhibition of HIV-1 Replication. J. Immunol. 166: 3780-3788 [Abstract] [Full Text]  
  • Southgate, T. D., Stone, D., Williams, J. C., Lowenstein, P. R., Castro, M. G. (2001). Long-Term Transgene Expression within the Anterior Pituitary Gland in Situ: Impact on Circulating Hormone Levels, Cellular and Antibody-Mediated Immune Responses. Endocrinology 142: 464-476 [Abstract] [Full Text]  
  • Sanchez, T. A., Habib, I., Leland Booth, J., Evetts, S. M., Metcalf, J. P. (2000). Zinc Finger and Carboxyl Regions of Adenovirus E1A 13S CR3 Are Important for Transactivation of the Cytomegalovirus Major Immediate Early Promoter by Adenovirus. Am. J. Respir. Cell Mol. Bio. 23: 670-677 [Abstract] [Full Text]  
  • Hagstrom, J. N., Couto, L. B., Scallan, C., Burton, M., McCleland, M. L., Fields, P. A., Arruda, V. R., Herzog, R. W., High, K. A. (2000). Improved muscle-derived expression of human coagulation factor IX from a skeletal actin/CMV hybrid enhancer/promoter. Blood 95: 2536-2542 [Abstract] [Full Text]  
  • Desurmont, C., Caillaud, J.-M., Emmanuel, F., Benoit, P., Fruchart, J. C., Castro, G., Branellec, D., Heard, J.-M., Duverger, N. (2000). Complete Atherosclerosis Regression After Human ApoE Gene Transfer in ApoE-Deficient/Nude Mice. Arterioscler. Thromb. Vasc. Bio. 20: 435-442 [Abstract] [Full Text]  
  • Lozier, J. N., Metzger, M. E., Donahue, R. E., Morgan, R. A. (1999). Adenovirus-Mediated Expression of Human Coagulation Factor IX in the Rhesus Macaque Is Associated With Dose-Limiting Toxicity. Blood 94: 3968-3975 [Abstract] [Full Text]  
  • Tyler, R. C., Fagan, K. A., Unfer, R. C., Gorman, C., McClarrion, M., Bullock, C., Rodman, D. M. (1999). Vascular inflammation inhibits gene transfer to the pulmonary circulation in vivo. Am. J. Physiol. Lung Cell. Mol. Physiol. 277: L1199-L1204 [Abstract] [Full Text]  
  • Morral, N., O'Neal, W., Rice, K., Leland, M., Kaplan, J., Piedra, P. A., Zhou, H., Parks, R. J., Velji, R., Aguilar-Cordova, E., Wadsworth, S., Graham, F. L., Kochanek, S., Carey, K. D., Beaudet, A. L. (1999). Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons. Proc. Natl. Acad. Sci. USA 96: 12816-12821 [Abstract] [Full Text]  
  • Tan, B. T., Wu, L., Berk, A. J. (1999). An Adenovirus-Epstein-Barr Virus Hybrid Vector That Stably Transforms Cultured Cells with High Efficiency. J. Virol. 73: 7582-7589 [Abstract] [Full Text]  
  • Amalfitano, A., McVie-Wylie, A. J., Hu, H., Dawson, T. L., Raben, N., Plotz, P., Chen, Y. T. (1999). Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-alpha -glucosidase. Proc. Natl. Acad. Sci. USA 96: 8861-8866 [Abstract] [Full Text]  
  • Jilling, T., Haddad, I. Y., Cheng, S. H., Matalon, S. (1999). Nitric oxide inhibits heterologous CFTR expression in polarized epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 277: L89-L96 [Abstract] [Full Text]  
  • Grzimek, N. K. A., Podlech, J., Steffens, H.-P., Holtappels, R., Schmalz, S., Reddehase, M. J. (1999). In Vivo Replication of Recombinant Murine Cytomegalovirus Driven by the Paralogous Major Immediate-Early Promoter-Enhancer of Human Cytomegalovirus. J. Virol. 73: 5043-5055 [Abstract] [Full Text]  
  • Pan, R.-Y., Xiao, X., Chen, S.-L., Li, J., Lin, L.-C., Wang, H.-J., Tsao, Y.-P. (1999). Disease-Inducible Transgene Expression from a Recombinant Adeno-Associated Virus Vector in a Rat Arthritis Model. J. Virol. 73: 3410-3417 [Abstract] [Full Text]  
  • Daly, T. M., Vogler, C., Levy, B., Haskins, M. E., Sands, M. S. (1999). Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease. Proc. Natl. Acad. Sci. USA 96: 2296-2300 [Abstract] [Full Text]  
  • Wirtz, S., Finotto, S., Kanzler, S., Lohse, A. W., Blessing, M., Lehr, H. A., Galle, P. R., Neurath, M. F. (1999). Cutting Edge: Chronic Intestinal Inflammation in STAT-4 Transgenic Mice: Characterization of Disease and Adoptive Transfer by TNF- Plus IFN-{gamma}-Producing CD4+ T Cells That Respond to Bacterial Antigens. J. Immunol. 162: 1884-1888 [Abstract] [Full Text]  
  • Lieber, A., He, C.-Y., Meuse, L., Himeda, C., Wilson, C., Kay, M. A. (1998). Inhibition of NF-kappa B Activation in Combination with Bcl-2 Expression Allows for Persistence of First-Generation Adenovirus Vectors in the Mouse Liver. J. Virol. 72: 9267-9277 [Abstract] [Full Text]  
  • Watanabe, M, Choudhry, A, Berlan, M, Singal, A, Siwik, E, Mohr, S, Fisher, S. (1998). Developmental remodeling and shortening of the cardiac outflow tract involves myocyte programmed cell death. Development 125: 3809-3820 [Abstract]  
  • Segev, D. L., Ha, T. U., Tran, T. T., Kenneally, M., Harkin, P., Jung, M., MacLaughlin, D. T., Donahoe, P. K., Maheswaran, S. (2000). Mullerian Inhibiting Substance Inhibits Breast Cancer Cell Growth through an NFkappa B-mediated Pathway. J. Biol. Chem. 275: 28371-28379 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»